Skip to content
Novai logo

Novai Alternatives & Competitors

8 companies similar to Novai — DARC, a retinal biomarker with AI, advancing drug development for AMD & glaucoma...

Companies similar to Novai

Gero logo — alternative to Novai

Gero

AI-driven drug discovery company focused on therapies targeting age-related diseases

iLOF logo — alternative to Novai

iLOF

Using AI and Photonics to enable a new era of personalized, precision medicine.

Scailyte logo — alternative to Novai

Scailyte

True precision medicine through single-cell science.

Cureteq AG - a Partex Company logo — alternative to Novai

Cureteq AG - a Partex Company

Asset management & drug development company - enabled by AI

Rival Readout

Competing with Novai? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Meta-flux logo — alternative to Novai

Meta-flux

Meta-flux is an AI biologist for pharmaceutical drug development.

1910 Genetics logo — alternative to Novai

1910 Genetics

Advancing small and large molecule drug discovery with a multimodal AI platform powered by...

Numerate logo — alternative to Novai

Numerate

Elevating Drug Discovery Through Advanced Computational Innovation

Iambic logo — alternative to Novai

Iambic

Better technology for better medicines | Nasdaq: IAM

About Novai

Novai, founded in 2020, is a UK-based startup at the vanguard of biotechnology, melding AI with groundbreaking retinal biomarker technology. Their innovation, DARC (Detection of Apoptosing Retinal Cells), seeks to revolutionize early detection and treatment in both ophthalmic and neurodegenerative diseases like macular...

Services

Early Detection of Eye and Brain Diseases, DARC AI Algorithm Insights, Clinical Trial Management, Preclinical Research, Pharmaceutical Collaboration

Target Customers

Patients, Clinicians, Pharmaceutical Companies, Healthcare Professionals

Business keywords

Drug Development, Pharmaceutical, Ophthalmology, Glaucoma, Age-related Macular Degeneration, Retinal, Neurodegeneration, Alzheimer's Disease, Multiple Sclerosis, Biomarker

Business Model

B2B, SaaS, DaaS

Revenue Model

Project Based, Service Fee, Licensing

Frequently Asked Questions

Companies similar to Novai include Gero, iLOF, Scailyte, Cureteq AG - a Partex Company, Meta-flux. They work in AI and Biotechnology and share Novai's focus on drug development and pharmaceutical.
Bounce Watch lists 8 companies that share Novai's industries and are closest to it in business tags, services, target customers, business model and size.
Novai, founded in 2020, is a UK-based startup at the vanguard of biotechnology, melding AI with groundbreaking retinal biomarker technology. Their innovation, DARC (Detection of Apoptosing Retinal Cells), seeks to revolutionize early detection and treatment in both ophthalmic and neurodegenerative diseases like macular...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Novai: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Novai on 11 Sep 2024. The 8 companies listed here were last checked between 12 Sep 2024 and 23 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout